Industry News
Outcomes of providing access to platelet function testing in a clinical setting
Nov 04, 2013
Results of the TRANSLATE-POPS trial presented at TCT 2013 According to a new study of heart attack patients treated with percutaneous coronary intervention (PCI), free access to platelet function testing had only a modest impact on anti-clotting drug selection and dosing... Read More
Potential benefits of shorter-term dual antiplatelet therapy in patients treated with a second generation drug-eluting stent
Nov 04, 2013
Results of the OPTIMIZE trial presented at TCT 2013 A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration could reduce bleeding risks and treatment costs... Read More
Among young adult women in the south HPV vaccination rates alarmingly low
Nov 03, 2013
Initiation and completion rates for the human papillomavirus vaccine series are significantly lower in the South than any other geographic region, according to a new study from researchers at the University of Texas Medical Branch at Galveston... Read More
Gene regulation technology increases survival rates in mice with glioblastoma
Nov 03, 2013
Glioblastoma multiforme (GBM), the brain cancer that killed Sen. Edward Kennedy and kills approximately 13,000 Americans a year, is aggressive and incurable. Now a Northwestern University research team is the first to demonstrate delivery of a drug that turns off a critical gene in this complex cancer, increasing survival rates significantly in animals with the deadly disease... Read More
Online lymphoma community 'The Lymphoma Hub' just launched
Nov 02, 2013
Led by La Fondazione Italiana Linfomi (FIL), a non-profit Italian professional lymphoma research organization, and supported by an unrestricted educational grant from Celgene Corporation, the Lymphoma Hub has been launched as a new online community for hematologists and oncologists treating lymphoma... Read More
Online lymphoma community 'The Lymphoma Hub' just launched
Nov 02, 2013
Led by La Fondazione Italiana Linfomi (FIL), a non-profit Italian professional lymphoma research organization, and supported by an unrestricted educational grant from Celgene Corporation, the Lymphoma Hub has been launched as a new online community for hematologists and oncologists treating lymphoma... Read More
US malaria cases reach highest in 40 years
Nov 01, 2013
The number of malaria cases in the US has reached a 40-year high, with 1,925 cases reported in 2011 - the highest number since 1971. This is according to a new report from the Centers for Disease Control and Prevention (CDC)... Read More
US malaria cases reach highest in 40 years
Nov 01, 2013
The number of malaria cases in the US has reached a 40-year high, with 1,925 cases reported in 2011 - the highest number since 1971. This is according to a new report from the Centers for Disease Control and Prevention (CDC)... Read More
Experimental drug MK-3475 shows promise in lung cancer
Nov 01, 2013
An experimental new cancer drug called MK-3475, which has shown dramatic promise for treating melanoma is also showing early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death of men and women worldwide. The preliminary results of a phase 1B study were presented by Dr... Read More
Brits unaware of symptoms of world's biggest cancer killer, lung cancer, according to new global survey
Nov 01, 2013
More than one in five people are unable to name any symptoms of the world's biggest cancer killer, according to a survey published to mark the start of Lung Cancer Awareness Month. The research, which was carried out by Ipsos MORI on behalf of the Global Lung Cancer Coalition, investigated awareness of the symptoms of lung cancer and smoking prevalence in 21 countries... Read More
Previous Page Next Page